We quantified the expression of NLRX1 in peripheral blood mononuclear cells (PBMCs) from MS patients (S2 Table) and found that PBMCs from relapsing-remitting MS (RRMS) patients express significantly higher levels of NLRX1 mRNA than healthy controls (Fig 6A). The gene discussed is NLRX1; the disease is relapsing-remitting multiple sclerosis.